Erythropoietin Gel as an Adjunct to Xenograft in the Surgical Management of Intrabony Periodontal Defects

• Status: Not yet recruiting
• Trial end date: 2023-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of the study is to evaluate the use of erythropoietin gel as an adjunct to xenograft in the surgical management of intrabony periodontal defects.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Ain Shams University
• Treatments: Epoetin Alfa

Criteria

Inclusion Criteria:

1. Both genders within age range of 20-50 years.

2. Patients diagnosed with periodontitis (Stage III).

3. Test site criteria: probing pocket depth ≥6mm and CAL ≥3mm. All these criteria will be determined after phase I conventional periodontal therapy.

4. Patients with three-wall intrabony defect.

5. Systemically free patients as evidenced by Burket's oral health history questionnaire .

6. Ability to attend the treatment sessions and comply with its procedures, the recall visits and oral hygiene protocol.

• Exclusion Criteria:

1. Smokers.

2. Pregnant or lactating females.

3. Patients under any medication that affect periodontal healing.

4. Vulnerable individuals